Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Acceptance and Commitment Therapy on Psychological Flexibility, Values, and Well-Being: A Single-Case Experimental Study (ACT-UNIVALLE)

26 mai 2026 mis à jour par: Universidad del Valle, Colombia

Acceptance and Commitment Therapy on Psychological Flexibility, Values, and Well-Being

The goal of this clinical trial is to evaluate the effects of a brief Acceptance and Commitment Therapy (ACT)-based group intervention on psychological flexibility, values-based functioning, and psychological well-being in university students aged 18 to 28 years presenting elevated levels of emotional distress and psychological risk indicators.

The main questions it aims to answer are:

Does a brief ACT-based intervention reduce experiential avoidance and cognitive fusion in university students? Does the intervention improve present-moment awareness, values-based functioning, life satisfaction, and psychological flourishing?

Participants will:

Complete repeated self-report assessments across 13 measurement points distributed throughout baseline, intervention, and follow-up phases.

Participate in five weekly ACT-based group intervention sessions delivered by trained clinical psychologists.

Engage in experiential ACT exercises focused on acceptance, mindfulness, cognitive defusion, values clarification, and committed action.

Complete between-session activities and behavioral practices related to the ACT processes addressed during the intervention.

Participate in follow-up assessments to evaluate maintenance of treatment effects over time.

Aperçu de l'étude

Description détaillée

University students frequently experience elevated levels of emotional distress, including symptoms of anxiety, depression, stress, worry, and psychological maladjustment. Brief interventions based on Acceptance and Commitment Therapy (ACT) have shown promising results in reducing experiential avoidance and cognitive fusion while promoting psychological flexibility and well-being.

The present study evaluates the effects of a brief ACT-based intervention protocol delivered in a group format using a Single-Case Experimental Design (SCED) with repeated measurements across baseline, intervention, and follow-up phases. The intervention focuses on core ACT processes, including acceptance, cognitive defusion, present-moment awareness, values clarification, and committed action.

Participants completed repeated assessments of psychological flexibility processes and well-being indicators across thirteen measurement points distributed throughout the study phases. The investigators hypothesize that the ACT-based intervention will produce reductions in experiential avoidance and cognitive fusion, together with improvements in present-moment awareness, values-based functioning, life satisfaction, and flourishing.

Type d'étude

Interventionnel

Inscription (Réel)

12

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Valle del Cauca Department
      • Cali, Valle del Cauca Department, Colombie, 760032
        • Faculty of Psychology, Universidad del Valle

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Oui

La description

Inclusion Criteria:

University students aged 18 years or older Interest in strengthening mental health and psychological well-being Voluntary agreement to participate in the study

High-risk scores on at least one of the following screening instruments:

Depression Anxiety Stress Scales (DASS-21) General Health Questionnaire (GHQ-12) State Worry Questionnaire-11 (SWQ-11)

Exclusion Criteria:

Current psychological or psychiatric treatment Current use of psychiatric medication Diagnosis related to developmental or learning difficulties Failure to attend intervention sessions Incomplete participation in study assessments

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: ACT-Based Brief Group Intervention
The intervention consisted of a brief ACT-based group protocol delivered weekly by trained clinical psychologists. The protocol targeted core ACT processes including acceptance, cognitive defusion, present-moment awareness, values clarification, and committed action. Sessions incorporated experiential exercises, metaphors, mindfulness practices, reflective activities, and between-session behavioral tasks designed to promote psychological flexibility and psychological well-being in university students.

The intervention consisted of a brief group-based Acceptance and Commitment Therapy (ACT) protocol designed to promote psychological flexibility and psychological well-being in university students presenting elevated emotional distress and psychological risk indicators. The protocol was grounded in the functional contextual approach and targeted core ACT processes, including acceptance, cognitive defusion, present-moment awareness, values clarification, and committed action.

Participants were organized into small groups of 5 to 8 individuals and attended five weekly intervention sessions conducted by trained clinical psychologists with at least five years of clinical experience. Prior to implementation, therapists completed specialized ACT training delivered by an expert clinician with extensive experience in Acceptance and Commitment Therapy.

The intervention protocol included an initial preliminary session focused on motivational engagement, informed consent procedures, feedback rega

Autres noms:
  • ACT Brief
  • ACT Protocol Group
  • ACT Intervention

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Mindful Attention Awareness Scale (MAAS)
Délai: Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks
The Mindful Attention Awareness Scale (MAAS) is a 15-item self-report questionnaire designed to assess present-moment attention and awareness in daily life. Items are rated on a 6-point Likert-type scale ranging from 1 ("almost always") to 6 ("almost never"). Total scores are calculated by summing item responses, with higher scores indicating greater mindfulness and present-moment awareness.
Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks
Acceptance and Action Questionnaire-II (AAQ-II)
Délai: Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
The Acceptance and Action Questionnaire-II (AAQ-II) is a 7-item self-report questionnaire designed to assess experiential avoidance and psychological inflexibility. Items are rated on a 7-point Likert-type scale ranging from 1 ("never true") to 7 ("always true"). Total scores are calculated by summing item responses, with higher scores indicating greater experiential avoidance and psychological inflexibility.
Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
Cognitive Fusion Questionnaire (CFQ)
Délai: Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
The Cognitive Fusion Questionnaire (CFQ) is a 7-item self-report questionnaire designed to assess cognitive fusion. Items are rated on a 7-point Likert-type scale ranging from 1 ("never true") to 7 ("always true"). Total scores are calculated by summing item responses, with higher scores indicating greater cognitive fusion.
Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Valuing Questionnaire - Obstruction Subscale (VQ-Obstruction)
Délai: Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
The Valuing Questionnaire - Obstruction Subscale (VQ-Obstruction) is a 5-item self-report measure designed to assess barriers and interference with values-based living. Items are rated on a 7-point Likert-type scale ranging from 0 ("not at all true") to 6 ("completely true"). Higher scores indicate greater obstruction in valued living.
Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
Satisfaction With Life Scale (SWLS)
Délai: Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
The Satisfaction With Life Scale (SWLS) is a 5-item self-report questionnaire designed to assess global life satisfaction. Items are rated on a 7-point Likert-type scale ranging from 1 ("strongly disagree") to 7 ("strongly agree"). Total scores are calculated by summing item responses, with higher scores indicating greater life satisfaction.
Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
Flourishing Scale (FS)
Délai: Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.
The Flourishing Scale (FS) is an 8-item self-report questionnaire designed to assess psychological flourishing, including meaning in life, interpersonal relationships, competence, and optimism. Items are rated on a 7-point Likert-type scale ranging from 1 ("strongly disagree") to 7 ("strongly agree"). Total scores are calculated by summing item responses, with higher scores indicating greater psychological flourishing.
Weekly during baseline (4 weeks), intervention (6 weeks), and follow-up (3 weeks), up to 13 weeks.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 avril 2025

Achèvement primaire (Réel)

15 juin 2025

Achèvement de l'étude (Réel)

30 juin 2025

Dates d'inscription aux études

Première soumission

12 mai 2026

Première soumission répondant aux critères de contrôle qualité

26 mai 2026

Première publication (Réel)

2 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

2 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

26 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Termes MeSH pertinents supplémentaires

Autres numéros d'identification d'étude

  • Universidad del Valle
  • UNIVALLE-ACT-2025 (Autre identifiant: Faculty of Psychology, Universidad del Valle)
  • Faculty of Psychology (Autre identifiant: Faculty of Psychology, Universidad del Valle)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner